The study titled "Glucagon-like peptide-1 receptor agonists and pancreatic cancer: a meta-analysis with trial sequential analysis" by Pinto LC, Falcetta MR, Rados DV, Leitao CB, Gross JL was published in Scientific Reports in 2019 (volume 9, pages 1-6).
The research aimed to assess the potential association between the use of glucagon-like peptide-1 (GLP-1) receptor agonists and the risk of pancreatic cancer. Through a meta-analysis and trial sequential analysis, the authors analyzed existing evidence on this topic.
However, without access to the full article, specific findings and conclusions cannot be provided. It's important to consult the full study for a comprehensive understanding of their research methodology and results.
Learn more about pancreatic cancer
https://brainly.com/question/31831907
#SPJ11